{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:32:11Z","timestamp":1791851531630,"version":"4.3.4"},"reference-count":96,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Conventional management of hypoparathyroidism has focused upon maintaining the serum calcium with oral calcium and active vitamin D, often requiring high doses and giving rise to concerns about long-term consequences including renal and brain calcifications. Replacement therapy with PTH has recently become available. This paper summarizes the results of the findings and recommendations of the Working Group on Management of Hypoparathyroidism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition:<\/jats:title>\n                  <jats:p>Contributing authors reviewed the literature regarding physiology, pathophysiology, and nutritional aspects of hypoparathyroidism, management of acute hypocalcemia, clinical aspects of chronic management, and replacement therapy of hypoparathyroidism with PTH peptides. PubMed and other literature search engines were utilized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence synthesis:<\/jats:title>\n                  <jats:p>Under normal circumstances, interactions between PTH and active vitamin D along with the dynamics of calcium and phosphorus absorption, renal tubular handing of those ions, and skeletal responsiveness help to maintain calcium homeostasis and skeletal health. In the absence of PTH, the gastrointestinal tract, kidneys, and skeleton are all affected, leading to hypocalcemia, hyperphosphatemia, reduced bone remodeling, and an inability to conserve filtered calcium. Acute hypocalcemia can be a medical emergency presenting with neuromuscular irritability. The recent availability of recombinant human PTH (1\u201384) has given hope that management of hypoparathyroidism with the missing hormone in this disorder will provide better control and reduced needs for calcium and vitamin D.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Hypoparathyroidism is associated with abnormal calcium and skeletal homeostasis. Control with calcium and active vitamin D can be a challenge. The availability of PTH (1\u201384) replacement therapy may usher new opportunities for better control with reduced supplementation requirements.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2015-3910","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T18:01:14Z","timestamp":1457028074000},"page":"2313-2324","source":"Crossref","is-referenced-by-count":168,"title":["Management of Hypoparathyroidism: Present and Future"],"prefix":"10.1210","volume":"101","author":[{"given":"John P.","family":"Bilezikian","sequence":"first","affiliation":[{"name":"Columbia University College of Physicians & Surgeons (J.P.B., N.E.C., M.R.R.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Department of Surgery and Translational Medicine (M.L.B.), University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Cusano","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians & Surgeons (J.P.B., N.E.C., M.R.R.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital (M.M., J.T.P.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital (L.R.), 8000 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[{"name":"Geneva University Hospitals and Faculty of Medicine (R.R.), 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishaela R.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians & Surgeons (J.P.B., N.E.C., M.R.R.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Winer","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (K.K.W.), National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri A.","family":"Liberman","sequence":"additional","affiliation":[{"name":"Sackler School of Medicine (U.A.L.), Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John T.","family":"Potts","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital (M.M., J.T.P.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071615002146800_B1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-012088562-6\/50021-2","article-title":"Physiology of calcium and phosphate homeostasis","volume-title":"Dynamics of bone and cartilage metabolism","author":"Rizzoli","year":"2006"},{"key":"2020071615002146800_B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2011.05.038","article-title":"Vitamin D and intestinal calcium absorption","volume":"347","author":"Christakos","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"2020071615002146800_B3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02556309","article-title":"Time course of calcium absorption in humans: evidence for a colonic component","volume":"44","author":"Barger-Lux","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"2020071615002146800_B4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","article-title":"Calcium absorption and achlorhydria","volume":"313","author":"Recker","year":"1985","journal-title":"N Engl J Med"},{"key":"2020071615002146800_B5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ajcn\/47.1.93","article-title":"Calcium absorbability from milk products, an imitation milk, and calcium carbonate","volume":"47","author":"Recker","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"2020071615002146800_B6","doi-asserted-by":"crossref","first-page":"1217S","DOI":"10.3945\/ajcn.113.073007","article-title":"How sound is the science behind the dietary recommendations for dairy?","volume":"99","author":"Weaver","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"2020071615002146800_B7","doi-asserted-by":"crossref","first-page":"1256S","DOI":"10.3945\/ajcn.113.073056","article-title":"Dairy products, yogurts, and bone health","volume":"99","author":"Rizzoli","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"2020071615002146800_B8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00198-006-0320-x","article-title":"Comparative effects of oral aromatic and branched-chain amino acids on urine calcium excretion in humans","volume":"18","author":"Dawson-Hughes","year":"2007","journal-title":"Osteoporos Int"},{"key":"2020071615002146800_B9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ajcn\/49.2.372","article-title":"Meal effects on calcium absorption","volume":"49","author":"Heaney","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"2020071615002146800_B10","article-title":"Disorders of vitamin D action","volume-title":"Endotext.org","author":"Liberman","year":"2014"},{"key":"2020071615002146800_B11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1017\/S000711451300055X","article-title":"Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial","volume":"110","author":"Whisner","year":"2013","journal-title":"Br J Nutr"},{"key":"2020071615002146800_B12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-88-470-5376-2_37","article-title":"Hypoparathyroidism during magnesium deficiency or excess","volume-title":"Hypoparathyroidism","author":"Rizzoli","year":"2015"},{"key":"2020071615002146800_B13","first-page":"E313","article-title":"Nature of calcemic effect of 1,25-dihydroxyvitamin D3 in experimental hypoparathyroidism","volume":"244","author":"Hefti","year":"1983","journal-title":"Am J Physiol"},{"key":"2020071615002146800_B14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2013.10.005","article-title":"A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat","volume":"58","author":"Smith","year":"2014","journal-title":"Bone"},{"key":"2020071615002146800_B15","doi-asserted-by":"crossref","first-page":"e24486","DOI":"10.1371\/journal.pone.0024486","article-title":"Feeding blueberry diets in early life prevent senescence of osteoblasts and bone loss in ovariectomized adult female rats","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"2020071615002146800_B16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bone.2014.07.024","article-title":"Diet and gene interactions influence the skeletal response to polyunsaturated fatty acids","volume":"68","author":"Bonnet","year":"2014","journal-title":"Bone"},{"key":"2020071615002146800_B17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2011.07.003","article-title":"Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone","volume":"668","author":"Hie","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2020071615002146800_B18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3945\/jn.114.198598","article-title":"A grape-enriched diet increases bone calcium retention and cortical bone properties in ovariectomized rats","volume":"145","author":"Hohman","year":"2015","journal-title":"J Nutr"},{"key":"2020071615002146800_B19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/79.2.326","article-title":"The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial","volume":"79","author":"Atkinson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"2020071615002146800_B20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/9781118453926.ch71","article-title":"Hypocalcemia: Definition, etiology, pathogenesis, diagnosis, and management","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Schafer","year":"2013","edition":"8th ed"},{"key":"2020071615002146800_B21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"key":"2020071615002146800_B22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-8529(18)30171-3","article-title":"Hypocalcemic emergencies","volume":"22","author":"Tohme","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071615002146800_B24","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"BMJ"},{"key":"2020071615002146800_B25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1\u201384) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","journal-title":"Clin Ther"},{"key":"2020071615002146800_B26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1530\/EJE-11-1094","article-title":"Use of recombinant human parathyroid hormone in hypocalcemic cardiomyopathy","volume":"166","author":"Ballane","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071615002146800_B27","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.bone.2006.02.024","article-title":"Post surgical hypoparathyroidism (HP): Treatment with teriparatide (TP)","volume":"38","author":"Castellano","year":"2006","journal-title":"Bone"},{"key":"2020071615002146800_B28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-08-0269","article-title":"Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide","volume":"159","author":"Puig-Domingo","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2020071615002146800_B29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1542-4758.2009.00380.x","article-title":"Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH","volume":"13","author":"Mahajan","year":"2009","journal-title":"Hemodial Int"},{"key":"2020071615002146800_B30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpeds.2011.09.022","article-title":"Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism","volume":"160","author":"Cho","year":"2012","journal-title":"J Pediatr"},{"key":"2020071615002146800_B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/07315724.2001.10719038","article-title":"Absorbability and cost effectiveness in calcium supplementation","volume":"20","author":"Heaney","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"2020071615002146800_B32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jbmr.5650030303","article-title":"Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate","volume":"3","author":"Harvey","year":"1988","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4158\/EP10241.CR","article-title":"Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism","volume":"17","author":"Milman","year":"2011","journal-title":"Endocr Pract"},{"key":"2020071615002146800_B34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-137-3-200208060-00024","article-title":"Tetany secondary to the use of a proton-pump inhibitor","volume":"137","author":"Subbiah","year":"2002","journal-title":"Ann Intern Med"},{"key":"2020071615002146800_B35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/014556131008900209","article-title":"Proton pump inhibitor suppression of calcium absorption presenting as respiratory distress in a patient with bilateral laryngeal paralysis and hypocalcemia","volume":"89","author":"Zaya","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"2020071615002146800_B36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2105\/AJPH.83.8.1155","article-title":"Lead content in 70 brands of dietary calcium supplements","volume":"83","author":"Bourgoin","year":"1993","journal-title":"Am J Public Health"},{"key":"2020071615002146800_B37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/02652030500316959","article-title":"Lead content of dietary calcium supplements available in Brazil","volume":"23","author":"Mattos","year":"2006","journal-title":"Food Addit Contam"},{"key":"2020071615002146800_B38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jada.2004.07.022","article-title":"Is coral calcium a safe and effective supplement?","volume":"104","author":"Blumberg","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"2020071615002146800_B39","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/jbmr.2255","article-title":"Increased calcium absorption from synthetic stable amorphous calcium carbonate: double-blind randomized crossover clinical trial in postmenopausal women","volume":"29","author":"Vaisman","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071615002146800_B41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(74)91348-8","article-title":"1,25-dihydroxycholecalciferol and 1\u03b1-hydroxycholecalciferol in hypoparathyroidism","volume":"2","author":"Russell","year":"1974","journal-title":"Lancet"},{"key":"2020071615002146800_B42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM197510232931702","article-title":"Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 \u03b1,25-dihydroxyvitamin D","volume":"293","author":"Kooh","year":"1975","journal-title":"N Engl J Med"},{"key":"2020071615002146800_B43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0026-0495(75)90055-4","article-title":"Effects of 1\u03b1-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism","volume":"24","author":"Neer","year":"1975","journal-title":"Metabolism"},{"key":"2020071615002146800_B44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1530\/eje.0.1360052","article-title":"Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis","volume":"136","author":"Mortensen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071615002146800_B45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1982.03320310085047","article-title":"Metabolites and analogues of vitamin D. Which for what?","volume":"247","author":"Haussler","year":"1982","journal-title":"JAMA"},{"key":"2020071615002146800_B46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.1994.tb03923.x","article-title":"Hypoparathyroidism\u2013a long-term follow-up experience with 1 \u03b1-vitamin D3 therapy","volume":"40","author":"Halabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071615002146800_B47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.1.6053.78","article-title":"Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1\u03b1-hydroxylated derivatives","volume":"1","author":"Kanis","year":"1977","journal-title":"Br Med J"},{"key":"2020071615002146800_B48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-2005-865724","article-title":"Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review","volume":"113","author":"Quack","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071615002146800_B49","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/jc.2010-1999","article-title":"Vitamin D toxicity due to a commonly available \u201cover the counter\u201d remedy from the Dominican Republic","volume":"96","author":"Lowe","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B52","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N Engl J Med"},{"key":"2020071615002146800_B54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.1986.02140160057032","article-title":"Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide","volume":"140","author":"Santos","year":"1986","journal-title":"Am J Dis Child"},{"key":"2020071615002146800_B55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","article-title":"Association between activating mutations of calcium-sensing receptor and Bartter's syndrome","volume":"360","author":"Watanabe","year":"2002","journal-title":"Lancet"},{"key":"2020071615002146800_B56","doi-asserted-by":"crossref","first-page":"E2090","DOI":"10.1210\/jc.2012-2301","article-title":"Magnesium supplementation does not affect blood calcium level in treated hypoparathyroid patients","volume":"97","author":"Lubi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B57","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B58","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B59","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B60","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020071615002146800_B61","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Guidelines for the management of hypoparathyroidism: Summary statement from the First International Workshop","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1210\/jc.2012-2747","article-title":"Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism","volume":"98","author":"Boyce","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071615002146800_B64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2020071615002146800_B65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","article-title":"Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry","volume":"16","author":"Schousboe","year":"2013","journal-title":"J Clin Densitom"},{"key":"2020071615002146800_B66","unstructured":"HypoPARAthyroidism Association Inc. http:\/\/www.hypopara.org."},{"key":"2020071615002146800_B67","unstructured":"Hypopara\n              UK\n            \n          . http:\/\/hypopara.org.uk\/home.php."},{"key":"2020071615002146800_B68","unstructured":"National Organization of Rare Diseases. https:\/\/rarediseases.org\/rare-diseases\/hypoparathyroidism."},{"key":"2020071615002146800_B69","unstructured":"EURODIS Rare Diseases Europe. http:\/\/www.eurordis.org\/."},{"key":"2020071615002146800_B70","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1\u201384) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B71","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"key":"2020071615002146800_B72","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B73","article-title":"Natpara [package insert]","year":"2015"},{"key":"2020071615002146800_B74","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B75","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B76","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B77","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1\u201334 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J Pediatr"},{"key":"2020071615002146800_B79","doi-asserted-by":"crossref","first-page":"e88237","DOI":"10.1371\/journal.pone.0088237","article-title":"Recombinant human parathyroid hormone related protein 1\u201334 and 1\u201384 and their roles in osteoporosis treatment","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2020071615002146800_B80","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","article-title":"PTH(1\u201384) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment","volume":"28","author":"Sikjaer","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B81","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"key":"2020071615002146800_B82","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1\u201384) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1\u201384): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B84","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615002146800_B85","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1\u201384): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B86","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1\u201384) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020071615002146800_B88","article-title":"Efficacy and safety of low dose recombinant parathyroid hormone (rhPTH[1\u201384]) in hypoparathyroidism: the RELAY study","author":"Vokes"},{"key":"2020071615002146800_B89","unstructured":"Study of safety and efficacy of a rhPTH[1\u201384] of fixed doses of 25 and 50 mcg in adults with hypoparathyrodism (RELAY). ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01268098. Accessed September 11, 2014"},{"key":"2020071615002146800_B90","unstructured":"A open-label study investigating the safety and tolerability of NPSP558, a recombinant human parathyroid hormone (rhPTH[1\u201384]), for the treatment of adults with hypoparathyroidism - a clinical extension study (RACE). ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01297309. Accessed September 11, 2014"},{"key":"2020071615002146800_B91","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.2555","article-title":"Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1\u201334 (hPTH 1\u201334) replacement therapy in hypoparathyroidism","volume":"30","author":"Gafni","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"key":"2020071615002146800_B93","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1\u201384 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol Pathol"},{"key":"2020071615002146800_B94","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1359\/jbmr.061111","article-title":"Osteosarcoma and teriparatide?","volume":"22","author":"Harper","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B95","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020071615002146800_B96","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: a decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/6\/2313\/10496620\/jcem2313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/6\/2313\/10496620\/jcem2313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:29:17Z","timestamp":1594952957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/6\/2313\/2804738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-3910","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}